Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

89.06
+0.62000.70%
Post-market: 89.060.00000.00%19:30 EDT
Volume:818.97K
Turnover:72.74M
Market Cap:4.34B
PE:-20.60
High:89.81
Open:87.61
Low:86.99
Close:88.44
52wk High:151.02
52wk Low:44.42
Shares:48.77M
Float Shares:29.72M
Volume Ratio:1.40
T/O Rate:2.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3223
EPS(LYR):-3.7900
ROE:-1433.70%
ROA:-25.78%
PB:-339.81
PE(LYR):-23.50

Loading ...

Celcuity’s Phase 3 Viktoria-2 Trial of Gedatolisib as a First-Line Treatment for Hr+/Her2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients

THOMSON REUTERS
·
May 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Celcuity Inc expected to post a loss of $1.05 a share - Earnings Preview

Reuters
·
May 13

Celcuity to report Q1 results, host webcast and conference call after market close

Reuters
·
May 07

Is It Too Late To Consider Celcuity (CELC) After Its Recent Share Price Surge?

Simply Wall St.
·
May 07

Celcuity director David Dalvey reports disposal of 25,000 shares worth $3.52 million

Reuters
·
May 07

Celcuity director Richard E. Buller disposes of 9,000 common shares for $1,260,514

Reuters
·
May 07

Top Midday Gainers

MT Newswires Live
·
May 05

Celcuity rises 17.1%

TIPRANKS
·
May 04

Celcuity price target raised to $189 from $141 at Craig-Hallum

TIPRANKS
·
May 04

HC Wainwright Upgrades Celcuity to Buy From Neutral, Adjusts Price Target to $165 From $94

MT Newswires Live
·
May 04

Celcuity Shares Climb on Positive Breast-Cancer Drug Trial Results

Dow Jones
·
May 04

S&P 500 Futures Fall In Premarket Trading; Victory Capital, Black Hills Lag

Dow Jones
·
May 04

Guggenheim Keeps Their Buy Rating on Celcuity (CELC)

TIPRANKS
·
May 04

Celcuity Inc : H.c. Wainwright Raises to Buy From Neutral; Raises Target Price to $165 From $94

THOMSON REUTERS
·
May 04

Celcuity upgraded to Buy from Neutral at H.C. Wainwright

TIPRANKS
·
May 04

Celcuity price target raised to $160 from $150 at Citizens

TIPRANKS
·
May 04

Celcuity Is Maintained at Buy by Needham

Dow Jones
·
May 04

Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Boston Scientific (BSX)

TIPRANKS
·
May 04

Celcuity Inc : Needham Raises Target Price to $155 From $122

THOMSON REUTERS
·
May 04